Porras-Méndez CMV, Reyes-Jiménez AE, Terán-González JO, Castro-D’Franchis LJ

Language: Spanish
References: 9
Page: 254-258
PDF size: 262.29 Kb.

ABSTRACT

Background: Infection with human immunodeficiency virus (HIV) is considered a chronic disease with use of antiretroviral therapy and the development of illnesses unrelated to it, such as metabolic syndrome and cardiovascular diseases.
Objective: To determine the prevalence of metabolic syndrome in patients with HIV-infection, in antiretroviral treatment, ascribed at North Central Hospital of Pemex.
Material and method: A descriptive, observational, retrospective, crosssectional study was done to determine the prevalence of metabolic syndrome and its relationship to antiretroviral treatment in HIV patients assigned in the North Central Hospital of Pemex; study χ² test was used.
Results: Metabolic syndrome was found in 35 of 40 patients on antiretroviral treatment. The most frequent metabolic disorder was hypertriglyceridemia with an average of 259.85 mg/dL (χ²=0.57). Antiretroviral group with the highest association with metabolic syndrome was of nucleoside reverse transcriptase inhibitors (NRTIs) in 30 patients (χ²=0.32).
Conclusions: Metabolic syndrome occurs more frequently in patients with HIV mainly receiving NRTIs. The prevalence of metabolic syndrome is high in the population studied, leading us to establish measures of primary prevention, early intervention and thus reduce the morbidity, mortality and costs resulting from the complications of metabolic syndrome.

REFERENCES

1. Malvestutto CD, Aberg JA. Coronary heart disease in people infected with HIV. Cleve Clin J Med 2010;77:547-556.

2. Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet 2013;328:1525-1533.

3. Ferreira Rdos S, Cassaro DC, Domingos H, Pontes ER, et al. The effects of a diet formulation with oats, soybeans, and flax on lipid profiles and uricemia in patients with AIDS and dyslipidemia. Rev Soc Bras Med Trop 2013;46:691-697.

4. Baggaley R, White RG, Boily MC. HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention. Int J Epidemiol 2010;39:1048-1063.

5. Grant PM, Komarow L, Andersen J, Sereti I, et al. Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs deferred ART during an opportunistic infection. PLoS One 2010;5:11416.

6. Fitch K, Abbara S, LeeH, Stavrou E, et al. Effects of lifestyle modification and metformin on atherosclerotic indices among HIV-infected patients with the metabolic syndrome. AIDS 2012;26:587-597.

7. Paula AA, Falcão MC, Pacheco AG. Metabolic syndrome in HIV-infected individuals: underlying mechanisms and epidemiological aspects. AIDS Res Ther 2013;10:32.

8. Hemkens LG, Bucher HC. HIV infection and cardiovascular disease. Eur Heart J 2014;35:1373-1381.

9. Lacerda HR, et al. Association of inflammatory cytokines and endothelial adhesion molecules with immunological, virological, and cardiometabolic disease in HIV-infected individuals. J Inter Soc Inter Cytokine Res 2014;34:385-393.